01:09 PM EDT, 04/29/2025 (MT Newswires) -- (Updates with stock price movement in the headline and second paragraph)

Novo Nordisk A/S ( NVO ) and Hims & Hers Health ( HIMS ) partnered to enable US consumers to access NovoCare pharmacy directly through the Hims platform with a bundled offering of all dose strengths of Wegovy and a Hims membership for $599 a month, the companies said Tuesday.

Hims shares jumped 26% in recent Tuesday trading, and Novo Nordisk ( NVO ) rose 3.6%.

Price: 64.89, Change: +2.27, Percent Change: +3.63